Beauty Health (NASDAQ:SKIN) Announces Quarterly Earnings Results

Beauty Health (NASDAQ:SKIN) announced its quarterly earnings results on Wednesday. The company reported ($0.08) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.10) by $0.02, Zacks reports. Beauty Health had a negative return on equity of 44.83% and a negative net margin of 8.11%.

Beauty Health Price Performance

NASDAQ:SKIN traded up $0.06 during trading hours on Wednesday, reaching $1.42. The company had a trading volume of 649,943 shares, compared to its average volume of 1,325,838. The company has a quick ratio of 5.57, a current ratio of 6.56 and a debt-to-equity ratio of 9.23. The stock has a 50-day moving average of $1.59 and a two-hundred day moving average of $1.57. Beauty Health has a one year low of $0.91 and a one year high of $5.17. The firm has a market capitalization of $176.25 million, a PE ratio of -3.38 and a beta of 0.84.

Wall Street Analysts Forecast Growth

Separately, Canaccord Genuity Group lifted their price target on shares of Beauty Health from $1.25 to $1.75 and gave the company a “hold” rating in a research report on Wednesday, November 13th. One equities research analyst has rated the stock with a sell rating, three have given a hold rating and one has given a buy rating to the company’s stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Hold” and an average price target of $2.55.

About Beauty Health

The Beauty Health Company designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide. The company's flagship product includes HydraFacial that enhance the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums. Its products also comprise Syndeo, a Delivery System designs to connects providers to the consumer's preferences to create a more personalized experience; consumables, such as single-use tips, solutions, and serums used to provide a hydrafacial treatment; SkinStylus SteriLock Microsystem, a microneedling device used for the treatment of enhancing appearance of surgical or traumatic hypertrophic scars on the abdomen and facial acne scarring in Fitzpatrick skin types I, II, and III; and Keravive, a treatment for scalp health.